Although growth stock picks can be highly volatile, they can make good long-term investments. They may be well-known stars or quiet gems, but they do share one common attribute—they are growing at a higher-than-average rate within their industry, or within the market as a whole, and could keep growing for years or decades.
And keep in mind that we focus on growth stocks, which have a good long-term history and favourable prospects. We downplay momentum stocks that tend to attract many investors simply because they are moving faster than the market averages, but are liable to fall sharply when their momentum fades.
There’s room for growth stock investing in your portfolio, but make sure you follow our TSI Network three-part Successful Investor strategy for your overall portfolio:
- Invest mainly in well-established companies;
- Spread your money out across most if not all of the five main economic sectors (Manufacturing & Industry; Resources & Commodities; Consumer; Finance; Utilities);
- Downplay or avoid stocks in the broker/media limelight.
Make better stock picks when you read this FREE Special Report, Canadian Growth Stocks: WestJet Stock, RioCan Stock and More.
In the three months ended September 30, 2012, the company’s sales fell 0.2%, to $7.15 billion from $7.17 billion a year earlier. However, if you exclude the negative impact of foreign exchange rates, sales would have risen 4%. Overall same-store sales rose 1.9% in the quarter.
Earnings fell 3.5%, to $1.46 billion from $1.51 billion. Due to fewer shares outstanding, earnings per share fell 1.4%, to $1.43 from $1.45. On a constant-currency basis, earnings per share would have risen 4%. The company also raised its quarterly dividend by 10.0%, to $0.77 a share from $0.70. The new annual rate of $3.08 yields 3.5%.
...
This private company has developed Quillivant XR, a liquid drug that treats attention deficit/hyperactivity disorder (ADHD). Pfizer’s extensive marketing and distribution operations should help expand sales of Quillivant XR.
Based on future sales of this drug, this purchase could cost Pfizer a total of $700 million. That’s equal to 15% of the $4.7billion, or $0.62 a share, that it earned in the second quarter of 2012. The deal should close by the end of 2012.
...
ABB has spent over $7.6 billion on acquisitions, including the cash these companies held, since the start of 2011. Expanding by acquisition adds risk, but these purchases have helped ABB expand into new regions. They also nicely complement its current products.
For example, in January 2011 ABB paid $4.2 billion for Arkansas-based Baldor Electric Co., which makes electric motors and related products, such as conveyor belts, fans and pumps.
...
In July 2012, the company completed its $18.4- billion acquisition of North Carolina-based Goodrich Corp., which makes aircraft parts, including landing gear, wheels and brakes.
Meanwhile, United Technologies earned $1.25 bil- lion in the three months ended September 30, 2012. That’s down 3.3% from $1.3 billion a year earlier. Because of more shares outstanding, earnings per share fell 4.2%, to $1.37 from $1.43.
...
To cut the risk of further losses following the 2008 / 2009 financial crisis, the company continues to scale back its GE Capital subsidiary, which provides loans and other financial services to GE’s customers. This business now accounts for 31% of GE’s overall revenue and 45% of its earnings.
In the three months ended September 30, 2012, GE’s revenue rose 2.8%, to $36.3 billion from $35.4 billion a year earlier. Revenue from the industrial businesses rose 7.4%, partly because GE bought companies that supply equipment to oil and gas producers. That offset lower sales of wind-power gear. The company continues to shrink GE Capital. As a result, this division’s revenue fell 5.4%. Earnings rose 9.9%, to $3.8 billion from $3.5 billion. Because of fewer shares outstanding, earnings per share rose 12.5%, to $0.36 from $0.32.
...
Even so, the stock has made little progress during this time. That’s partly because more people are using mobile devices instead of computers running Microsoft software.
The company hopes to take advantage of rising demand for mobile access with its new Windows 8 operating system, which will work with smartphones and tablet computers as well as traditional computers.
...
Adobe’s revenue rose 6.6% in the three months ended August 31, 2012, to $1.08 billion from $1.03 billion a year earlier. Even so, that missed the consensus estimate of $1.1 billion.
The company is doing a good job of selling its Creative Cloud package of photo-editing and desktop-publishingprograms as a subscription service instead of a one-time purchase.
...
In its fiscal 2012 third quarter, which ended June 30, 2012, Fair Isaac’s earnings per share rose 1.7%, to $0.59 from $0.58. That matched the consensus estimate of $0.59. Revenue rose 6.5%, to $160.5 million from $150.7 million.
Research spending is a hidden plus
Sealy, which was founded in 1881, makes a wide range of spring-coil beds under the Sealy, Sealy Posturepedic, Sealy Embody, Stearns & Foster and Bassett brands.
The purchase lets Tempur-Pedic diversify into the market for traditional spring-coil beds. Right now, the company manufactures and distributes therapeutic mattresses and pillows made from its Tempur material. But that’s become a more competitive market because other mattress makers have introduced many new products and supported them with aggressive promotions.
...
This new service adds credit risk—the company will make loans of up to $800,000 to selected merchants—but the move should boost Amazon’s sales. That’s because the additional cash will let merchants stock more inventory to sell through the company’s websites, especially heading into the holiday season.
Amazon.com is still a hold.
...